Literature DB >> 23442064

Clues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors.

Marzia Varettoni1, Silvia Zibellini, Daniela Capello, Luca Arcaini, Davide Rossi, Cristiana Pascutto, Sara Rattotti, Silvia Mangiacavalli, Lara Pochintesta, Manuel Gotti, Gianluca Gaidano, Mario Cazzola.   

Abstract

We characterized immunoglobulin heavy chain (IGH) gene rearrangements and searched for clusters of stereotyped B-cell receptors in 123 patients with Waldenström macroglobulinemia (WM; n = 59) or immunoglobulin M monoclonal gammopathy of undetermined significance (IgM-MGUS) (n = 64). A productive monoclonal IGHV-D-J rearrangement was obtained in 99/123 patients (80%). Immunoglobulin heavy chain variable (IGHV) genes were mutated in 94/99 patients (95%) with a median somatic hypermutation rate of 6.7% (2.1-14.5). Compared with the normal B-cell repertoire, patients with WM/IgM-MGUS showed an over-representation of the IGHV3 subgroup (83% vs. 55%, p < 0.0001) and an under-representation of IGHV1 (7% vs. 14%, p = 0.04) and IGHV4 (7% vs. 23%, p = 0.0001) subgroups. At the gene level, in WM/IgM-MGUS there was an over-representation of IGHV3-23 (24% vs. 12%, p = 0.0003), IGHV3-64 (3% vs. < 1%, p = 0.003), IGHV3-7 (12% vs. 4%, p = 0.0001) and IGHV3-74 (9% vs. 2%, p < 0.0001), while IGHV4-39 was never used (0 vs. 5%, p = 0.03). Intra-WM/IgM-MGUS search for HCDR3 similarity showed no association fulfilling criteria for stereotyped receptors. WM/IgM-MGUS sequences were unrelated to known chronic lymphocytic leukemia (CLL), splenic marginal zone lymphoma (SMZL) or mantle cell lymphoma (MCL) subsets. In conclusion, the IGHV gene usage in WM and IgM-MGUS is remarkably biased as compared to the normal B-cell repertoire. WM and IgM-MGUS-specific HCDR3 clusters do not occur with a frequency detectable with currently available databases, not supporting a B-cell receptor-driven pathogenesis in WM and IgM-MGUS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23442064     DOI: 10.3109/10428194.2013.779689

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  15 in total

Review 1.  Cold agglutinin disease.

Authors:  Sigbjørn Berentsen
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

Review 2.  Targeting B-cell receptor signaling in leukemia and lymphoma: how and why?

Authors:  John C Allen; Fatima Talab; Joseph R Slupsky
Journal:  Int J Hematol Oncol       Date:  2016-05-26

Review 3.  B-cell receptor signaling as a driver of lymphoma development and evolution.

Authors:  Carsten U Niemann; Adrian Wiestner
Journal:  Semin Cancer Biol       Date:  2013-09-20       Impact factor: 15.707

4.  Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma.

Authors:  Ulla Randen; Gunhild Trøen; Anne Tierens; Chloé Steen; Abdirashid Warsame; Klaus Beiske; Geir E Tjønnfjord; Sigbjørn Berentsen; Jan Delabie
Journal:  Haematologica       Date:  2013-10-18       Impact factor: 9.941

5.  Landscape of immunoglobulin heavy chain gene repertoire and its clinical relevance to LPL/WM.

Authors:  Jun Wang; Yuting Yan; Wenjie Xiong; Ge Song; Yi Wang; Jiawei Zhao; Yujiao Jia; Chengwen Li; Zhen Yu; Ying Yu; Jiawen Chen; Yang Jiao; Tingyu Wang; Rui Lyu; Qinghua Li; Yueshen Ma; Wei Liu; Dehui Zou; Gang An; Qi Sun; Huijun Wang; Zhijian Xiao; Jianxiang Wang; Lugui Qiu; Shuhua Yi
Journal:  Blood Adv       Date:  2022-07-12

Review 6.  The promise and challenge of high-throughput sequencing of the antibody repertoire.

Authors:  George Georgiou; Gregory C Ippolito; John Beausang; Christian E Busse; Hedda Wardemann; Stephen R Quake
Journal:  Nat Biotechnol       Date:  2014-01-19       Impact factor: 54.908

7.  Clonal B cells in Waldenström's macroglobulinemia exhibit functional features of chronic active B-cell receptor signaling.

Authors:  K V Argyropoulos; R Vogel; C Ziegler; G Altan-Bonnet; E Velardi; M Calafiore; A Dogan; M Arcila; M Patel; K Knapp; C Mallek; Z R Hunter; S P Treon; M R M van den Brink; M L Palomba
Journal:  Leukemia       Date:  2016-02-12       Impact factor: 11.528

8.  Autoantibodies against mono- and tri-methylated lysine display similar but also distinctive characteristics.

Authors:  Zhiqiang Wang; Younan Ma; Fan Liu; Linjie Chen; Ruitong Gao; Wei Zhang
Journal:  PLoS One       Date:  2017-02-21       Impact factor: 3.240

Review 9.  Waldenström macroglobulinemia: clinical and immunological aspects, natural history, cell of origin, and emerging mouse models.

Authors:  Siegfried Janz
Journal:  ISRN Hematol       Date:  2013-09-09

10.  Clonotypic analysis of immunoglobulin heavy chain sequences in patients with Waldenström's macroglobulinemia: correlation with MYD88 L265P somatic mutation status, clinical features, and outcome.

Authors:  Loizos Petrikkos; Marie-Christine Kyrtsonis; Maria Roumelioti; George Georgiou; Anna Efthymiou; Tatiana Tzenou; Panayiotis Panayiotidis
Journal:  Biomed Res Int       Date:  2014-08-14       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.